GlobeNewswire
Immix Biopharma Announces Closing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
📈
AI Sentiment
Highly Positive
8/10
Immix Biopharma Inc. News
Latest updates and market news for IMMX
5 news
Dec 7 - Dec 13, 2025
Page 1
GlobeNewswire
Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
📊
AI Sentiment
Positive
6/10
GlobeNewswire
At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis
📈
AI Sentiment
Highly Positive
8/10
Share this news page